vs
Side-by-side financial comparison of GENCOR INDUSTRIES INC (GENC) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.
GENCOR INDUSTRIES INC is the larger business by last-quarter revenue ($23.6M vs $13.3M, roughly 1.8× OCULAR THERAPEUTIX, INC). GENCOR INDUSTRIES INC runs the higher net margin — 14.6% vs -488.0%, a 502.6% gap on every dollar of revenue. On growth, OCULAR THERAPEUTIX, INC posted the faster year-over-year revenue change (-22.4% vs -25.0%). GENCOR INDUSTRIES INC produced more free cash flow last quarter ($10.1M vs $-57.1M). Over the past eight quarters, OCULAR THERAPEUTIX, INC's revenue compounded faster (-5.3% CAGR vs -23.9%).
Gencor Industries Inc is a leading manufacturer of heavy construction and infrastructure equipment, specializing in asphalt production plants, thermal combustion systems, and supporting road-building machinery. It primarily serves North American and global construction markets, supplying products to both public sector infrastructure projects and private commercial construction operators.
Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.
GENC vs OCUL — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.6M | $13.3M |
| Net Profit | $3.4M | $-64.7M |
| Gross Margin | 28.7% | 88.0% |
| Operating Margin | 13.2% | -526.5% |
| Net Margin | 14.6% | -488.0% |
| Revenue YoY | -25.0% | -22.4% |
| Net Profit YoY | -9.8% | -33.6% |
| EPS (diluted) | $0.23 | $-0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.6M | $13.3M | ||
| Q3 25 | $18.8M | $14.5M | ||
| Q2 25 | $27.0M | $13.5M | ||
| Q1 25 | $38.2M | $10.7M | ||
| Q4 24 | $31.4M | $17.1M | ||
| Q3 24 | $20.9M | $15.4M | ||
| Q2 24 | $25.6M | $16.4M | ||
| Q1 24 | $40.7M | $14.8M |
| Q4 25 | $3.4M | $-64.7M | ||
| Q3 25 | $1.9M | $-69.4M | ||
| Q2 25 | $3.8M | $-67.8M | ||
| Q1 25 | $6.1M | $-64.1M | ||
| Q4 24 | $3.8M | $-48.4M | ||
| Q3 24 | $1.5M | $-36.5M | ||
| Q2 24 | $2.6M | $-43.8M | ||
| Q1 24 | $6.2M | $-64.8M |
| Q4 25 | 28.7% | 88.0% | ||
| Q3 25 | 24.2% | 87.8% | ||
| Q2 25 | 26.5% | 85.6% | ||
| Q1 25 | 29.7% | 88.2% | ||
| Q4 24 | 27.6% | 92.8% | ||
| Q3 24 | 25.6% | 89.9% | ||
| Q2 24 | 23.9% | 90.8% | ||
| Q1 24 | 30.3% | 91.0% |
| Q4 25 | 13.2% | -526.5% | ||
| Q3 25 | -1.2% | -472.3% | ||
| Q2 25 | 11.6% | -502.6% | ||
| Q1 25 | 17.0% | -597.5% | ||
| Q4 24 | 14.7% | -296.1% | ||
| Q3 24 | 5.9% | -298.2% | ||
| Q2 24 | 7.8% | -265.1% | ||
| Q1 24 | 17.4% | -214.0% |
| Q4 25 | 14.6% | -488.0% | ||
| Q3 25 | 10.2% | -477.3% | ||
| Q2 25 | 14.2% | -503.9% | ||
| Q1 25 | 16.0% | -598.7% | ||
| Q4 24 | 12.1% | -283.3% | ||
| Q3 24 | 6.9% | -236.6% | ||
| Q2 24 | 10.0% | -266.3% | ||
| Q1 24 | 15.3% | -438.9% |
| Q4 25 | $0.23 | $-0.27 | ||
| Q3 25 | $0.13 | $-0.38 | ||
| Q2 25 | $0.26 | $-0.39 | ||
| Q1 25 | $0.42 | $-0.38 | ||
| Q4 24 | $0.26 | $-0.25 | ||
| Q3 24 | $0.10 | $-0.22 | ||
| Q2 24 | $0.17 | $-0.26 | ||
| Q1 24 | $0.42 | $-0.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $147.7M | $737.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $215.2M | $654.3M |
| Total Assets | $228.9M | $808.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $147.7M | $737.1M | ||
| Q3 25 | $136.3M | $344.8M | ||
| Q2 25 | $136.0M | $391.1M | ||
| Q1 25 | $143.7M | $349.7M | ||
| Q4 24 | $130.1M | $392.1M | ||
| Q3 24 | $115.4M | $427.2M | ||
| Q2 24 | $116.6M | $459.7M | ||
| Q1 24 | $117.1M | $482.9M |
| Q4 25 | — | — | ||
| Q3 25 | $0 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $215.2M | $654.3M | ||
| Q3 25 | $211.8M | $258.2M | ||
| Q2 25 | $209.9M | $305.9M | ||
| Q1 25 | $206.1M | $265.9M | ||
| Q4 24 | $200.0M | $315.3M | ||
| Q3 24 | $196.1M | $352.0M | ||
| Q2 24 | $194.7M | $377.7M | ||
| Q1 24 | $192.1M | $408.0M |
| Q4 25 | $228.9M | $808.1M | ||
| Q3 25 | $222.6M | $410.9M | ||
| Q2 25 | $220.2M | $451.3M | ||
| Q1 25 | $223.9M | $405.9M | ||
| Q4 24 | $218.2M | $457.9M | ||
| Q3 24 | $208.1M | $490.4M | ||
| Q2 24 | $201.8M | $517.1M | ||
| Q1 24 | $206.0M | $538.9M |
| Q4 25 | — | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.1M | $-54.2M |
| Free Cash FlowOCF − Capex | $10.1M | $-57.1M |
| FCF MarginFCF / Revenue | 43.0% | -430.9% |
| Capex IntensityCapex / Revenue | 4.1% | 21.4% |
| Cash ConversionOCF / Net Profit | 3.23× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-3.2M | $-216.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.1M | $-54.2M | ||
| Q3 25 | $-275.0K | $-50.7M | ||
| Q2 25 | $-23.9M | $-55.2M | ||
| Q1 25 | $12.4M | $-44.7M | ||
| Q4 24 | $14.8M | $-39.4M | ||
| Q3 24 | $-3.2M | $-36.6M | ||
| Q2 24 | $-1.0M | $-24.8M | ||
| Q1 24 | $11.7M | $-33.9M |
| Q4 25 | $10.1M | $-57.1M | ||
| Q3 25 | $-1.3M | $-56.7M | ||
| Q2 25 | $-24.4M | $-56.5M | ||
| Q1 25 | $12.3M | $-46.6M | ||
| Q4 24 | $14.5M | $-39.6M | ||
| Q3 24 | $-3.3M | $-36.6M | ||
| Q2 24 | $-1.4M | $-25.5M | ||
| Q1 24 | $11.7M | $-34.1M |
| Q4 25 | 43.0% | -430.9% | ||
| Q3 25 | -6.8% | -390.0% | ||
| Q2 25 | -90.4% | -419.7% | ||
| Q1 25 | 32.2% | -435.6% | ||
| Q4 24 | 46.1% | -232.0% | ||
| Q3 24 | -15.8% | -237.6% | ||
| Q2 24 | -5.6% | -155.4% | ||
| Q1 24 | 28.7% | -231.1% |
| Q4 25 | 4.1% | 21.4% | ||
| Q3 25 | 5.4% | 41.2% | ||
| Q2 25 | 1.8% | 9.3% | ||
| Q1 25 | 0.4% | 18.1% | ||
| Q4 24 | 1.0% | 1.2% | ||
| Q3 24 | 0.4% | 0.6% | ||
| Q2 24 | 1.5% | 4.5% | ||
| Q1 24 | 0.0% | 1.7% |
| Q4 25 | 3.23× | — | ||
| Q3 25 | -0.14× | — | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | 2.04× | — | ||
| Q4 24 | 3.88× | — | ||
| Q3 24 | -2.22× | — | ||
| Q2 24 | -0.41× | — | ||
| Q1 24 | 1.87× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
